Compound Solutions, Inc. (CSI), exclusive global distributor of patent-protected TeaCrine®, today announced explosive sales numbers. The announcement comes after a 2015 fiscal year that saw the premium, branded ingredient grow from three product launches in 2014 to 53 in 2015—and a further 32 in just the first quarter of 2016. CSI expects growh to continue at this extraordinary pace.
Gnosis is truthfully proud to announce a great confirmation and [...]
Chemi Nutra proudly announces the introduction of novel, water dispersible specialty phosphatidylserine (PS) and phosphatidic acid (PA) phospholipid ingredient compounds, for use in applications including beverages, RTDs, shots, and gels, while providing documented, unique health benefits.
Gnosis is pleased to announce that on February 16th, 2016 Quatrefolic®, the biologically active form of the naturally-occurring predominant form of folate, has been approved as food additive by the Ministry of Health of the People’s Republic of China (MOH).
A randomized, double-blind, placebo-controlled, human clinical trial just published in the Journal of the International Society of Sports Nutrition showed that those who consumed 2.4 grams of Kyowa’s L-citrulline significantly increased plasma L-arginine levels and a reduction in time to complete a cycle ergometer exercise trial.
Gnosis is delighted to announce that on February 22nd, 2016 the Brazilian National Health Surveillance Agency, ANVISA, has approved the use of vitaMK7, the Natural Vitamin K2 as MK7, as Novel Food Ingredient to be used in finished products in Brazil.
In this Energy special we have collected ingredients to energize your formulations.
Stratum Nutrition and joint-venture partner, ESM Technologies, the manufacturer of innovative, commercialized eggshell and eggshell membrane wellness ingredients, are pleased to announce a new independent clinical trial has published in the International Journal of Clinical Medicine evaluating their joint health ingredient NEM® brand eggshell membrane.
innoVactiv, a Canadian company dedicated to the development of science-based specialty ingredients, announces new study results demonstrating for the first time the superior potency of InSea2® the upcoming Engredea tradeshow (Booth # 764; March 11-13, Anaheim, CA).
Blis Technologies and Stratum Nutrition are pleased to announce a new publication in the journal, Therapeutics and Clinical Risk Management, of an independent clinical trial evaluating the oral probiotic, BLIS K12®, and its effectiveness in preventing pharyngo-tonsillar infections, or recurrent tonsillitis, in children. The study was conducted using BLIS K12, a rare strain of Streptococcus salivarius.